Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Ambition Mica Ltd

AMBITION
BSE
2.96
Company Overview
Alert
Watchlist
Note

Ambition Mica Ltd

AMBITION
BSE
2.96
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
4Cr
Close
Close Price
2.96
Industry
Industry
Laminates
PE
Price To Earnings
PS
Price To Sales
0.33
Revenue
Revenue
13Cr
Rev Gr TTM
Revenue Growth TTM
-41.01%
PAT Gr TTM
PAT Growth TTM
-92.34%
Peer Comparison
How does AMBITION stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
AMBITION
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
Quarter
Revenue
RevenueCr
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
Operating Profit
Operating ProfitCr
OPM
OPM%
Other Income
Other IncomeCr
Interest Expense
Interest ExpenseCr
Depreciation
DepreciationCr
PBT
PBTCr
Tax
TaxCr
PAT
PATCr
Growth YoY
PAT Growth YoY%
NPM
NPM%
EPS
EPS

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Revenue
RevenueCr
3638495289846437231313
Growth
Revenue Growth%
7.428.94.873.2-6.3-23.6-42.9-37.9-43.94.2
Expenses
ExpensesCr
3334444684785934581416
Operating Profit
Operating ProfitCr
35555652-35-1-3
OPM
OPM%
8.412.19.610.26.07.07.56.0-155.9-11.6-23.4
Other Income
Other IncomeCr
0000000-2233
Interest Expense
Interest ExpenseCr
12222444322
Depreciation
DepreciationCr
00111111111
PBT
PBTCr
1333310-5-37-1-3
Tax
TaxCr
111110-10011
PAT
PATCr
1222211-5-37-1-3
Growth
PAT Growth%
100.8-1.414.79.4-45.7-16.3-629.5-607.197.1-188.7
NPM
NPM%
2.44.53.53.82.41.41.5-14.2-161.1-8.3-23.1
EPS
EPS
3.06.01.41.61.50.80.7-3.5-24.5-0.7-2.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Equity Capital
Equity CapitalCr
33412151515151515
Reserves
ReservesCr
249314151510-26-27
Current Liabilities
Current LiabilitiesCr
18192735494348414039
Non Current Liabilities
Non Current LiabilitiesCr
87461517141368
Total Liabilities
Total LiabilitiesCr
31324455928993793435
Current Assets
Current AssetsCr
2021314175697464218
Non Current Assets
Non Current AssetsCr
10111215172019151327
Total Assets
Total AssetsCr
31324455928993793435

Cash Flow

Consolidated
Standalone
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Operating Cash Flow
Operating Cash FlowCr
22-11-14-2571-3
Investing Cash Flow
Investing Cash FlowCr
-10-1-2-1-3-1110
Financing Cash Flow
Financing Cash FlowCr
-1-231182-4-8-13
Net Cash Flow
Net Cash FlowCr
101-13-30000
Free Cash Flow
Free Cash FlowCr
12-20-17-5481-3
CFO To PAT
CFO To PAT%
279.7137.7-41.555.9-661.6-144.5508.8-131.6-1.5306.3
CFO To EBITDA
CFO To EBITDA%
81.051.8-15.020.9-263.8-28.8103.2309.8-1.6219.3

Ratios

Consolidated
Standalone
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
002073582877108
Price To Earnings
Price To Earnings
0.00.011.837.327.024.26.90.00.00.0
Price To Sales
Price To Sales
0.00.00.41.40.70.30.10.20.40.6
Price To Book
Price To Book
0.00.01.65.02.00.90.20.3-0.8-0.6
EV To EBITDA
EV To EBITDA
3.11.96.116.214.09.77.015.9-1.0-27.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
19.927.226.431.121.526.928.419.8-144.32.3
OPM
OPM%
8.412.19.610.26.07.07.56.0-155.9-11.6
NPM
NPM%
2.44.53.53.82.41.41.5-14.2-161.1-8.3
ROCE
ROCE%
16.925.419.117.39.69.06.9-1.6-214.96.3
ROE
ROE%
19.125.213.613.57.53.93.2-20.6319.28.5
ROA
ROA%
2.85.43.93.52.31.31.1-6.5-107.6-3.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
**Ambition Mica Limited** is an Indian manufacturer and trader specializing in **Decorative Laminated Sheets** and **Door Skins**. The company serves the premium and mid-range interior infrastructure sectors, providing surfacing materials for residential and commercial applications such as furniture, cabinetry, and wall paneling. The company is currently undergoing a **Corporate Insolvency Resolution Process (CIRP)** under the **Insolvency and Bankruptcy Code (IBC)** following the discovery of significant financial irregularities and subsequent defaults. --- ### **Core Product Portfolio and Market Positioning** The company operates within a single business segment: the manufacturing and marketing of laminates. Its product mix is designed to cater to the aesthetic requirements of modern interior design. * **Decorative Laminated Sheets:** High-pressure laminates (HPL) featuring diverse textures, metal finishes, and wood grains. These are primarily used for sales counters, reception desks, and home furniture. * **Door Skins:** Specialized aesthetic laminates designed specifically for door surfacing. * **Revenue Mix:** Historically, the business has been bifurcated into direct manufacturing and trading. However, recent data shows a total reliance on manufactured goods. * **FY 2022-23 Revenue:** **₹1,157.18 Lakhs** (100% from manufactured decorative laminates). * **FY 2021-22 Revenue:** **₹1,806.97 Lakhs**. * **Performance Trend:** The company experienced a **35.9% year-on-year decrease** in sales value as of **March 31, 2023**, reflecting operational distress. --- ### **Manufacturing Infrastructure and Supply Chain** The company’s production capabilities are centered in **Dehgam, Gujarat**, though the operational status of the facility is currently complicated by leasehold and legal issues. * **Facility Location:** Two leasehold plots in Gujarat. * **Plot 1 (Survey No. 311):** The lease expired on **May 1, 2024**, creating a critical legal hurdle for continued operations. * **Plot 2 (Survey No. 309):** The lease remains valid until **March 31, 2040**. * **Production Inputs:** The process is heavily reliant on **industrial solvents and chemicals**. * **Supply Chain Vulnerability:** Geopolitical instability has historically restricted the availability of imported raw materials, leading to price volatility and reduced capacity utilization. --- ### **Corporate Insolvency and Resolution Framework** Ambition Mica was admitted into insolvency by the **NCLT Ahmedabad** on **March 06, 2024**, following a default of **₹3.97 Crore** to an operational creditor. The **Committee of Creditors (CoC)** recently approved a **90-day extension** to the CIRP period, extending the resolution window beyond the original **December 01, 2024** deadline. #### **Proposed Resolution Payouts and Capital Restructuring** The financial recovery framework is centered on a proposed total payout of **₹13.80 Crore** to **Secured Financial Creditors**. | Category | Amount / Provision | | :--- | :--- | | **Total Payout to Secured Creditors** | **₹13.80 Crore** | | — Allocation against Corporate Debtor Assets | **₹5.80 Crore** | | — Allocation against Guarantor Land (Mrs. Monghiben Patel) | **₹8.00 Crore** | | **Upfront Payment** | **₹4.96 Crore** (within **30 days** of NCLT approval) | | **Interest on Delayed Payment** | **9% per annum** | | **Operational Creditors (Govt/Others)** | **₹1 Lakh** each (nominal provision) | #### **Post-Resolution Equity Structure** Upon NCLT approval, the company’s capital will be restructured as follows: * **Issuance to Secured Creditors:** **1,00,000 equity shares** (₹10 face value) distributed based on admitted claims. * **Issuance to Public Stakeholders:** **2,55,000 equity shares** (₹10 face value) issued to existing shareholders as of a future Record Date. --- ### **Comparative Analysis of Resolution Applicants** Multiple entities have submitted bids to acquire and restart the company. Proposals vary significantly in their treatment of land assets and working capital. | Resolution Applicant | Proposed Outlay | Key Terms & Strategy | | :--- | :--- | :--- | | **Subhlaxmi Investment Advisory** | **₹1.00 Crore** | Focus on settling CIRP costs (**₹30L**) and secured creditors (**₹65L**). | | **Shivpriya Infra & Rolence Pharma (A)** | **₹1.00 Crore** | Acquisition of all assets/liabilities; requests leasehold transfer. | | **Shivpriya Infra & Rolence Pharma (B)** | **₹3.50 Crore** | Includes **₹2.5 Crore** specifically to purchase the two plots of land. | | **Successful Resolution Applicant (SRA)** | **₹13.80 Crore** | Comprehensive settlement including guarantor land and share issuance. | --- ### **Critical Risk Factors and Financial Irregularities** Investors must note that the company’s "Going Concern" status is under material uncertainty due to a history of internal fraud and legal disputes. * **CFO Misappropriation:** A former CFO was arrested for an estimated **₹28 Crore fraud** (2015–2021), involving fictitious purchases and intentional misstatement of inventory. * **Audit Disclaimer:** Statutory auditors have issued a **Disclaimer of Opinion**, citing an inability to verify: * Stock values and GST Input Tax Credits. * Unexplained payments of **₹3.85 Crore – ₹3.89 Crore** made outside normal operations. * Trade receivables totaling **₹1,820.04 Lakhs**, of which **₹1,538.60 Lakhs** have been outstanding for **1–3 years**. * **Asset Ownership Conflict:** The land housing the factory is owned by the mother of a suspended director and is currently in the possession of **Axis Bank**, not the company itself. * **Regulatory Non-compliance:** Trading on the **BSE** is currently **suspended** due to non-payment of annual listing fees for **FY 2021-22** and **FY 2022-23**. * **Contingent Liabilities:** Includes **₹40.13 Lakhs** in disputed Central Sales Tax and various TDS/TCS defaults. --- ### **Strategic Recovery Path** The company’s survival depends on the successful execution of the NCLT-approved Resolution Plan. Key growth levers identified in the proposals include: 1. **Working Capital Infusion:** Bidders have earmarked **₹1 Crore to ₹2 Crore** to resume manufacturing operations. 2. **Land Acquisition:** Strategic purchase of non-CIRP land to stabilize the manufacturing base. 3. **PUFE Recoveries:** Any funds recovered from **Preferential, Undervalued, Fraudulent, or Extortionate** transactions are reserved for **Secured Financial Creditors**, potentially reducing the net debt burden.